Leo Cancer Care Have Qualified for the Final Jury of the iF DESIGN Award 2021

We are proud to announce that we have qualified for the Final Jury of the iF Design Awards 2021.

We are overjoyed that our first product, Marie™, has been selected, out of 10,000 submissions, to make it through to the Final Jury of the iF Design Award. The iF Design Award was established in Germany in 1953 and is an internationally recognised sign of great design.

Leo Cancer Care’s Upright Radiotherapy Product, Marie™, through to the Final Jury of the iF Design Award 2021

Marie™ is our state-of-the-art, upright proton radiotherapy solution, that allows for imaging and treatment in one place providing a significant improvement to treatment accuracy and patient experience.

This recognition is a testament to our incredible team at Leo Cancer Care and the hard work of our collaborators on this project, DCA Design International. We wish to say a huge thank you to all those who have been involved in the development of Marie.

The final round of judging will occur in March 2021 and we are keeping our fingers crossed that we are further recognised in this prestigious competition.